| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Usage # |
|---|
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1070.json | Hepatitis A | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1078.json | Measles | active | | | 2021-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1080.json | Measles | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1085.json | Measles, Mumps and Rubella (MMR) Vaccine Administered | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1086.json | Measles, Mumps and Rubella (MMR) Vaccine Administered | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1087.json | Mumps | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1089.json | Mumps | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1098.json | Rubella | active | | | 2021-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.110.json | Rubella | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1104.json | Varicella Zoster | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1105.json | Varicella Zoster | active | | | 2025-01 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1106.json | Varicella Zoster Vaccine (VZV) Administered | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1107.json | Varicella Zoster Vaccine (VZV) Administered | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1109.json | Hepatitis A Vaccine Administered | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1110.json | Hepatitis A Vaccine Administered | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1111.json | Hepatitis B Vaccine Administered | active | | | 2021-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1112.json | Hepatitis B Vaccine Administered | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1115.json | Child Influenza Vaccine Administered | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1116.json | Child Influenza Vaccine Administered | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1117.json | Inactivated Polio Vaccine (IPV) Administered | active | | | 2021-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1118.json | Inactivated Polio Vaccine (IPV) Administered | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1119.json | Pneumococcal Conjugate Vaccine Administered | active | | | 2023-11 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1120.json | Rotavirus Vaccine (3 dose schedule) Administered | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1121.json | Rotavirus Vaccine (2 dose schedule) Administered | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1123.json | Genital Herpes | active | | | 2024-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1124.json | Genital Herpes | active | | | 2024-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1128.json | Lab Tests for Sexually Transmitted Infections | active | | | 2022-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1129.json | Chlamydia Screening | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1133.json | Pneumococcal Conjugate Vaccine Administered | active | | | 2024-11 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1135.json | HPV Test | active | | | 2024-11 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1148.json | Rotavirus Vaccine (2 Dose Schedule) Administered | active | | | 2019-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1149.json | Rotavirus Vaccine (3 Dose Schedule) Administered | active | | | 2019-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1150.json | Advanced Illness | active | | | 2025-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1151.json | Advanced Illness | active | | | 2025-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1152.json | HiB Vaccine (3 dose schedule) | active | | | 2021-12 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1153.json | HiB Vaccine (3 dose schedule) Administered | active | | | 2021-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1154.json | HiB Vaccine (4 dose schedule) | active | | | 2021-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1155.json | HiB Vaccine (4 dose schedule) Administered | active | | | 2021-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1156.json | HiB Vaccine (3 dose schedule) Administered | active | | | 2024-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1157.json | HiB Vaccine (4 dose schedule) Administered | active | | | 2024-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1158.json | Competing Conditions for Respiratory Conditions | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.11.1159.json | Competing Conditions for Respiratory Conditions | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1022.json | DTaP Vaccine Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1024.json | Hepatitis A | active | | | 2017-05 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1031.json | Measles, Mumps and Rubella (MMR) Vaccine Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1032.json | Mumps | active | | | 2017-05 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1037.json | Rubella | active | | | 2017-05 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1039.json | Varicella Zoster | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1040.json | Varicella Zoster Vaccine (VZV) Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1041.json | Hepatitis A Vaccine Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1042.json | Hepatitis B Vaccine Administered | active | | | 2022-09 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1044.json | Child Influenza Vaccine Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1045.json | Inactivated Polio Vaccine (IPV) Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1046.json | Pneumococcal Conjugate Vaccine Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1047.json | Rotavirus Vaccine (3 dose schedule) Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1048.json | Rotavirus Vaccine (2 dose schedule) Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1049.json | Genital Herpes | active | | | 2018-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1051.json | Lab Tests for Sexually Transmitted Infections | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1052.json | Chlamydia Screening | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1053.json | Measles | active | | | 2017-05 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1059.json | HPV Test | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1082.json | Advanced Illness | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1083.json | Hib Vaccine (3 dose schedule) | active | | | 2019-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1084.json | Hib Vaccine (3 dose schedule) Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1085.json | Hib Vaccine (4 dose schedule) | active | | | 2019-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1086.json | Hib Vaccine (4 dose schedule) Administered | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1087.json | Influenza Virus LAIV Vaccine | active | | | 2021-02 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.110.12.1088.json | Influenza Virus LAIV Vaccine Administered | active | | | 2021-02 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1012.json | Lab Tests During Pregnancy | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1013.json | Diagnostic Studies During Pregnancy | active | | | 2022-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1019.json | Pregnancy Test | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1022.json | Complications of Pregnancy, Childbirth and the Puerperium | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1023.json | Complications of Pregnancy, Childbirth and the Puerperium | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1028.json | Procedures for Sexual Activity | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1030.json | Procedures for Sexual Activity | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1031.json | Diagnosis for Sexual Activity | active | | | 2021-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1032.json | Diagnosis for Sexual Activity | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.11.1033.json | Procedures for Sexual Activity | active | | | 2021-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1007.json | Lab Tests During Pregnancy | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1008.json | Diagnostic Studies During Pregnancy | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1011.json | Pregnancy Test | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1012.json | Complications of Pregnancy, Childbirth and the Puerperium | active | | | 2022-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1016.json | Congenital or Acquired Absence of Cervix | active | | | 2024-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1017.json | Procedures Used to Indicate Sexual Activity | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.111.12.1018.json | Diagnoses Used to Indicate Sexual Activity | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.112.11.1024.json | Absence of Cervix | active | | | 2021-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.112.11.1025.json | Absence of Cervix | active | | | 2021-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.112.11.1026.json | Absence of Cervix | active | | | 2023-09 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1073.json | Osteoporosis Without Current Fracture | active | | | 2017-12 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1074.json | Osteoporosis Without Current Fracture | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1200.json | Osteoporosis With Current Fracture | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1201.json | Osteoporosis With Current Fracture | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1202.json | DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine | active | | | 2021-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1308.json | Frailty Diagnosis | active | | | 2024-11 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1309.json | Frailty Diagnosis | active | | | 2025-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1310.json | Frailty Symptom | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.11.1311.json | Frailty Symptom | active | | | 2023-11 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1038.json | Osteoporosis Without Current Fracture | active | | | 2024-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1050.json | Osteoporosis With Current Fracture | active | | | 2018-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1051.json | DXA (Dual energy Xray Absorptiometry) Scan | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1074.json | Frailty Diagnosis | active | | | 2019-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.113.12.1075.json | Frailty Symptom | active | | | 2019-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1021.json | Narcolepsy | active | | | 2018-08 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1023.json | Narcolepsy | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1024.json | Neurologic impairment | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1025.json | Neurologic impairment | active | | | 2017-05 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.11.1026.json | Neurologic impairment | active | | | 2021-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.12.1011.json | Narcolepsy | active | | | 2024-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.114.12.1012.json | Neurologic impairment | active | | | 2024-02 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1149.json | Substance Use Disorder Long Acting Medication | active | | | 2024-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.115.11.1248.json | Retinal or Dilated Eye Exam | active | | | 2025-01 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.115.12.1088.json | Retinal or Dilated Eye Exam | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1150.json | Substance Use Disorder Short Acting Medication | active | | | 2024-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1151.json | Substance Use Disorder Long Acting Medication Administration | active | | | 2025-01 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1152.json | Substance Use Disorder Short Acting Medication Administration | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1155.json | Substance Use Disorder Short Acting Medication Administration | active | | | 2023-11 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1156.json | Substance Use Disorder Long Acting Medication Administration | active | | | 2021-11 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1157.json | Substance Use Disorder Short Acting Medication Administration | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1163.json | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine | active | | | 2022-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1164.json | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine | active | | | 2022-02 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1165.json | Hospice Diagnosis | active | | | 2022-08 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1166.json | Hospice Diagnosis | active | | | 2022-08 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1167.json | Palliative Care Diagnosis | active | | | 2022-08 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1168.json | Palliative Care Diagnosis | active | | | 2022-08 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1169.json | Palliative Care Diagnosis | active | | | 2022-08 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.11.1031.json | Hyperthyroidism | active | | | 2018-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.11.1033.json | Hyperthyroidism | active | | | 2018-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.11.1034.json | Hyperparathyroidism | active | | | 2022-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.11.1036.json | Hyperparathyroidism | active | | | 2018-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.12.1015.json | Hyperthyroidism | active | | | 2024-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.117.12.1016.json | Hyperparathyroidism | active | | | 2024-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1170.json | Atomoxetine | active | | | 2022-09 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1171.json | Clonidine | active | | | 2024-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1172.json | Dexmethylphenidate | active | | | 2025-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1173.json | Dextroamphetamine | active | | | 2022-09 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1174.json | Lisdexamfetamine | active | | | 2022-09 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1176.json | Methylphenidate | active | | | 2024-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1177.json | Lower Body Fractures Excluding Ankle and Foot | active | | | 2022-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1178.json | Lower Body Fractures Excluding Ankle and Foot | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1179.json | Malignant Neoplasms of Lower and Unspecified Limbs | active | | | 2022-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.11.1042.json | Counseling for Physical Activity | active | | | 2019-03 | hl7 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.11.1077.json | Falls Screening | active | | | 2018-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.11.1097.json | CT Colonography | active | | | 2019-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.11.1220.json | Frailty Device SNOMED | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.12.1028.json | Falls Screening | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.12.1035.json | Counseling for Physical Activity | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.118.12.1300.json | Frailty Device | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1180.json | Malignant Neoplasms of Lower and Unspecified Limbs | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1181.json | Mechanical Complications Excluding Upper Body | active | | | 2022-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1182.json | Mechanical Complications Excluding Upper Body | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1183.json | Partial Arthroplasty of Hip | active | | | 2022-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1184.json | Partial Arthroplasty of Hip | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1188.json | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | | | 2022-12 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1189.json | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1190.json | Antibiotic Medications for Upper Respiratory Infection | active | | | 2025-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1193.json | Malignant Neoplasms | active | | | 2022-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1194.json | Malignant Neoplasms | active | | | 2022-09 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1196.json | Atherosclerosis of the Extremities | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1197.json | Atherosclerosis of the Extremities | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1198.json | Atherosclerosis of the Extremities | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1199.json | Lower Extremity Neurological Assessment Result or Finding | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1001.json | Disorders of the Immune System | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1003.json | Disorders of the Immune System | active | | | 2024-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1004.json | HIV Viral Load | active | | | 2025-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1008.json | HIV 2 | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1010.json | HIV 2 | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1011.json | Severe Combined Immunodeficiency | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.11.1012.json | Severe Combined Immunodeficiency | active | | | 2023-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.12.1001.json | Disorders of the Immune System | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.12.1002.json | HIV Viral Load | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.12.1003.json | HIV | active | | | 2024-01 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.120.12.1007.json | Severe Combined Immunodeficiency | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1200.json | Lower Extremity Neurological Tests | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1201.json | Lower Extremity Visual Inspection Result or Finding | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1202.json | Lower Extremity Visual Inspection Test | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1203.json | Monofilament Test Result or Finding | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1204.json | Monofilament Tests | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1205.json | Pedal Pulse Result or Finding | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1206.json | Peripheral Neuropathy | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1207.json | Peripheral Neuropathy | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1208.json | Peripheral Neuropathy | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1209.json | Amputation of Bilateral Feet | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.121.11.1011.json | Consultant Report | active | | | 2022-02 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.121.11.1028.json | BMI percentile | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.121.11.1030.json | Height | active | | | 2019-03 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.121.11.1031.json | Weight | active | | | 2017-05 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.121.12.1006.json | Consultant Report | active | | | 2024-09 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.121.12.1012.json | BMI percentile | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.121.12.1014.json | Height | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.121.12.1015.json | Weight | active | | | 2022-03 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1210.json | Amputation of Bilateral Feet | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1211.json | Amputation of Bilateral Feet | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1212.json | Amputation of Left Foot | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1213.json | Amputation of Left Foot | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1214.json | Amputation of Left Foot | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1215.json | Amputation of Right Foot | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1216.json | Amputation of Right Foot | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1217.json | Amputation of Right Foot | active | | | 2023-07 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1218.json | Amputation of Unspecified Foot | active | | | 2023-07 | hl7 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.1219.json | Amputation of Unspecified Foot | active | | | 2023-07 | hl7 | 1 |